Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
August 11, 2003
- DIAGNOSTIC NEWS IN BRIEF
August 11, 2003
- NEW PRODUCTS
August 11, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 11, 2003
- Warning against Facile Use of Antibiotics to Treat Colds: JRS GL
August 11, 2003
- AnGes MG Granted Patent Rights on HGF Gene Therapy
August 11, 2003
- Sosei Raises \1.6 Billion to Finance Development
August 11, 2003
- Part of Revised PAL Goes into Effect on July 30
August 11, 2003
- Financial Results in 1st Quarter
August 11, 2003
- National Medical Costs Rose 3.2% in FY2001: Korosho
August 11, 2003
- REGULATORY NEWS IN BRIEF
August 11, 2003
- Korosho Study Group Prepares Comprehensive GL on Lung Cancer
August 4, 2003
- PPTA Submits Comments on Blood Law to Korosho
August 4, 2003
- Only 35% of Migraine Sufferers Get Treatment
August 4, 2003
- BUSINESS NEWS IN BRIEF
August 4, 2003
- 70% of People Had Allergic Symptoms in Past Year: JMARI Survey
August 4, 2003
- Website News
August 4, 2003
- Ain Pharmaciez, Sogo Medical "Patterns of Success": Nomura Securities
August 4, 2003
- Financial Results in 1st Quarter
August 4, 2003
- Pharmacists 5th Most-trusted Professionals in Japan: Poll
August 4, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…